220 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Bought by Mowery & Schoenfeld Wealth Management LLC

Mowery & Schoenfeld Wealth Management LLC purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 220 shares of the medical equipment provider’s stock, valued at approximately $108,000.

A number of other large investors also recently modified their holdings of the company. Creekmur Asset Management LLC boosted its position in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 42 shares during the period. Ridgewood Investments LLC purchased a new stake in Intuitive Surgical during the 2nd quarter valued at about $26,000. Delos Wealth Advisors LLC grew its position in Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 57 shares during the last quarter. Godsey & Gibb Inc. increased its stake in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. Finally, LRI Investments LLC bought a new stake in Intuitive Surgical in the first quarter valued at approximately $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Truist Financial raised their price target on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a report on Monday, October 14th. Stifel Nicolaus increased their price objective on Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Raymond James raised their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $513.74.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 1,413 shares of the firm’s stock in a transaction that occurred on Friday, July 26th. The shares were sold at an average price of $438.60, for a total transaction of $619,741.80. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,414,931.60. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Intuitive Surgical news, EVP Robert Desantis sold 1,413 shares of the stock in a transaction on Friday, July 26th. The stock was sold at an average price of $438.60, for a total transaction of $619,741.80. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,414,931.60. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 2,943 shares of the business’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the completion of the transaction, the director now owns 12,275 shares of the company’s stock, valued at $5,441,507.50. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 51,455 shares of company stock worth $24,911,155. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded down $1.76 during mid-day trading on Thursday, reaching $510.82. The stock had a trading volume of 230,348 shares, compared to its average volume of 1,469,292. The company has a market capitalization of $181.19 billion, a price-to-earnings ratio of 92.52, a PEG ratio of 5.40 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $523.34. The company has a 50-day moving average price of $486.71 and a two-hundred day moving average price of $440.96.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.